PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Citation Tools

PDF +
Supplementary
Material

GI cancer

Original research

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Mangiapane LR, Nicotra A, Turdo A, et al

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

Gut Published Online First: 12 January 2021. doi: 10.1136/gutjnl-2020-323553